Dr. Ilyas Washington
A modified form of vitamin A may help prevent vision loss due to dry age-related macular degeneration and a juvenile form of macular degeneration called Stargardt disease. This potential treatment developed by Dr Washington and colleagues can reduce or eliminate the formation of damaging, clumpy deposits (called dimers) of vitamin A that are associated with the onset of these degenerative eye diseases.When given to mice with the same genetic defect as humans with Stargardt disease, the modified vitamin A resulted in fewer vitamin A dimers, better overall eye health, and improved vision. Importantly, the modified vitamin A worked exactly as normal vitamin A, making it an attractive potential therapy for preventing blindness in humans. Read more about Dr. Washington's research.